SGLT2 Inhibitors Added to ESC Guidelines for Treatment of Chronic HFrEF

August 27th 2021, 7:00am


The 5-year update could help solidify the role of sodium glucose co-transporter 2 (SGLT2) inhibitors in treating heart failure, years after the first evidence of their effectiveness emerged.

Developing a PROM to Measure Severity of Chronic Cough

August 21st 2021, 9:00pm


Researchers conducted a literature survey about chronic cough symptoms to create a patient-reported outcome measurement (PROM) tool in order to measure cough severity.

Disparities Persist in the Long Term for 5-Year AYA Survivors of Hodgkin Lymphoma

August 4th 2021, 9:30pm


Treatment-related modifications have resulted in improved long-term outcomes for all adolescent and young adult (AYA) survivors of Hodgkin lymphoma, but new research highlights that racial, ethnic, and socioeconomic status disparities persist in the long term.

Dr Ron Eccles Outlines the Challenges of the Placebo Effect for Cough Medicines

July 24th 2021, 3:00pm


Patients may find a placebo effect beneficial, but it causes issues in a clinical trial and makes it difficult to understand the efficacy of a pharmacological agent, said Ron Eccles, BSc, PhD, DSc, emeritus professor at Cardiff University.

Dynamic MRD Can Drive Clinical Decisions in AML

July 23rd 2021, 1:00pm


Dynamic measurable residual disease (MRD) can be used to optimize postremission treatment for young patients with acute myeloid leukemia (AML).

Therapy Can Prevent Infections in Immunocompromised Patients With Leukemia

July 16th 2021, 5:00pm


A new treatment using human immune cells can prevent infections in patients with leukemia who have a weakened immune system due to treatment for their disease.

Following Approval of Ruxolitinib, Relative Survival of pMF Has Slightly Increased

July 16th 2021, 12:45pm


The nationwide, population-based study analyzed data on over 1900 patients with primary myelofibrosis (pMF), comparing rates of survival from 2001-2010 with 2011-2018.

Researchers Review Current Status of HSCT for Myelofibrosis

July 10th 2021, 5:40pm


In a recent review, researchers describe what is currently known about allogenic hemopoietic stem cell transplant (HSCT) for myelofibrosis.

Genomic Landscapes and Outcomes in Elderly Patients With AML

July 9th 2021, 1:30pm


Posters presented at the European Hematology Association 2021 Virtual Congress evaluated acute myeloid leukemia (AML) in elderly patients.

NAFLD Increases Mortality in Children and Young Adults Over the Long Term

July 8th 2021, 8:30pm


A long-term Swedish study found that nonalcoholic fatty liver disease (NALFD) significantly increased mortality in children and young adults, particularly due to cancer, cardiometabolic disease, and liver disease.